Accumulating evidence suggests that the response of bacteria to antibiotics is significantly
affected by the presence of other interacting microbes. These interactions are not typically …

Evolution is the hallmark of life. Descriptions of the evolution of microorganisms have
provided a wealth of information, but knowledge regarding “what happened” has precluded …

Bacteria possess a diverse range of mechanisms for inhibiting competitors, including
bacteriocins, tailocins, type VI secretion systems and contact-dependent inhibition (CDI) …

Chronic respiratory diseases including chronic rhinosinusitis, otitis media, asthma, cystic
fibrosis, non-CF bronchiectasis, and chronic obstructive pulmonary disease are a major …

Biofilms are consortia of microorganisms that form collectives through the excretion of
extracellular matrix compounds. The importance of biofilms in biological, industrial and …

Biofilms are multispecies communities, in which bacteria constantly compete with one
another for resources and niches. Bacteria produce many antibiotics and toxins for …

Pseudomonas aeruginosa (PA) is an opportunistic pathogen that causes high mortality in
cystic fibrosis patients. Treatment failures often occur due to the emergence of antibiotic …

Bacteria can form dense communities called biofilms, where cells are embedded in a self-
produced extracellular matrix. Exploiting competitive interactions between strains within the …

Over millions of years of evolution, bacteria have developed complex strategies for intra-and
interspecies interactions and competition for ecological niches and resources. Contact …

Many bacteria kill competitors using short-range weapons, such as the Type VI secretion
system and contact dependent inhibition (CDI). Although these weapons can deliver …